RARA and acute promyelocytic leukemia: The combination of 0.2 μM As3+ and 0.2 μM As4S4 obviously enhanced degradation of the PML-RARα oncoprotein and promoted differentiation of NB4 and primary APL cells via the retinoic acid signaling pathway.